Italia markets open in 5 hours 56 minutes

SWTX Dec 2025 45.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
14,000,00 (0,00%)
Alla chiusura: 10:16AM EDT
Schermo intero
Chiusura precedente14,00
Aperto14,00
Denaro10,00
Domanda17,00
Prezzo d'esercizio45,00
Scadenza2025-12-19
Min-Max giorno14,00 - 14,00
Contratto - Min-MaxN/D
Volume2
Open InterestN/D
  • GlobeNewswire

    SpringWorks Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

    – Presented additional Phase 3 DeFi data at ASCO demonstrating clinically significant reductions in pain and substantial reductions in tumor volume and T2 hyperintensity with nirogacestat treatment – – Completed enrollment of Phase 2 trial evaluating nirogacestat in patients with ovarian granulosa cell tumors – – Highlighted encouraging Phase 1 and 2 clinical data from emerging pipeline programs at AACR and EHA – STAMFORD, Conn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (